Survodutide
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 32
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Microgynon® (Reference treatment (R)) followed by BI 456906 and Microgynon® (Test treatment (T)) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.